1. Komaba H, Kakuta T, Fukagawa M. Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol. 2011. 15:797–809.
2. Stracke S, Keller F, Steinbach G, Henne-Bruns D, Wuerl P. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism. Nephron Clin Pract. 2009. 111:c102–c109.
3. Roshan A, Kamath B, Roberts S, Atkin SL, England RJ. Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful? Clin Otolaryngol. 2006. 31:198–203.
4. Moor JW, Roberts S, Atkin SL, England RJ. Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck. 2011. 33:293–296.
5. Maxwell PH, Winearls CG. Recurrence of autonomous hyperparathyroidism in dialysis patients. Nephrol Dial Transplant. 1997. 12:2195–2200.
6. Freriks K, Hermus AR, de Sevaux RG, Bonenkamp HJ, Biert J, den Heijer M, et al. Usefulness of intraoperative parathyroid hormone measurements in patients with renal hyperparathyroidism. Head Neck. 2010. 32:1328–1335.
7. Haustein SV, Mack E, Starling JR, Chen H. The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery. 2005. 138:1066–1071.
8. Richards ML, Grant CS. Current applications of the intraoperative parathyroid hormone assay in parathyroid surgery. Am Surg. 2007. 73:311–317.
9. Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM. Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg. 2002. 137:341–344.
10. Echenique Elizondo M, Diaz-Aguirregoitia FJ, Amondarain JA, Vidaur F. Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal. World J Surg. 2005. 29:1504–1509.
11. Hargrove GM, Pasieka JL, Hanley DA, Murphy MB. Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol. 1999. 19:559–564.
12. Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg. 2001. 233:65–69.
13. Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, et al. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg. 2003. 387:348–354.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003. 42:4 Suppl 3. S1–S201.
15. Yamashita H, Cantor T, Uchino S, Watanabe S, Ogawa T, Moriyama T, et al. Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism. World J Surg. 2005. 29:169–173.
16. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol. 1997. 13:78–86.